Safe blood collection and blood analysis

Last edited: | Sample Integrity - Back to overview

Use safe and appropriate products, focus on the patient

Save blood collection for a quality blood sample starts with patient-centered behavior, choosing the right products for the individual situation as well as providing a safe, protected environment for both patient and healthcare worker.

Ensure the best possible conditions

As a next step, safety in the blood analysis process means being sure of the best possible conditions for a correct analysis and accurate diagnosis, which requires observation of sample handling guidelines including correct labeling and transportation. Ensuring that specimens are correctly labeled helps to prevent any risk of misdiagnosis or errors in therapy and medication.

By transporting samples safely, which means in accordance with biohazard regulations, not only keeps staff members involved in the process protected from possible risk of infection, it also keeps the samples in the best possible condition up until analysis.

Know the guidelines

Furthermore, being aware of existing guidelines and avoiding possible errors, such as applying a tourniquet too firmly or for too long, can make an essential contribution to producing samples of quality.

When available, make use of digitalization

Application of up-to-date tools that bring digitalization to routine healthcare procedures like blood collection increases the level of automation, reducing the chances of human error. It could, for example, provide on-screen guidance taking the healthcare worker through the order of draw and handling of specimens, making safe and reliable blood collection easily achievable, thereby significantly reducing the risk caused by handling mistakes, whilst at the same time increasing efficiency.

Thus, a combination of being aware of suitable product choices for different conditions, being aware of best practice guidelines and using the best available technology can all combine for consistent reliable sample quality and good results.

Safety and value, it’s in our blood

Protecting patients, clinicians and accuracy are topics to be covered in more detail here in the coming months. To ensure you don’t miss out, subscribe to the series here.

Please select your intention and contact the person who is responsible for you!

* required field


This product information is addressed exclusively to healthcare professionals. Devices of Greiner Bio-One are to be used by properly trained healthcare professionals only in accordance with the relevant Instructions for Use (IFU). For a listing of indications, contraindications, precautions and warnings, please refer to the Instructions for Use which accompanies each product or is available for download from our website at (Download Center). For more information contact your local Greiner Bio-One sales representative or visit our website. 

All information is provided without guarantee despite careful processing. Any liability, warranty or guarantee of Greiner Bio-One GmbH is excluded. All rights, errors and changes are reserved. If not stated otherwise, Greiner Bio-One GmbH has all copyrights and/or other (user-)rights in this documents, in particular to signs such as the mentioned (word-picture-)brands and logos. Any use, duplication or any other use of the rights of Greiner Bio-One GmbH is expressly prohibited.

Testimonials appearing on this blog communicate their individual experiences regarding the use of our products and/or services. The opinions expressed in this publication are those of the interview partner; they do not purport to reflect the opinions or views of Greiner Bio-One.

This information partly expresses opinions of our customers and/or experiences of individuals and do not purport to reflect the opinions or views of Greiner Bio-One.

Media owner and publisher: Greiner Bio-One GmbH, Bad Haller Str. 32, 4550 Kremsmünster

Sign-up to our newsletter or request more information here
Register now and you will receive our regular Greiner Bio-One News on current topics to stay up-to-date.

We redirected you to your country page. To go back to the previous page, please click the button.

You are not viewing your country page. To switch to your country, please click the button.